SCHEMBL5969367

SCHEMBL5969367

COc1ccc(C2CC(=O)NN2)cc1OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 14/20 0.56
PDE4B Q07343 8/20 0.56
PDE4C Q08493 8/20 0.56
PDE4D Q08499 8/20 0.56
GFER P55789 1/20 0.51
PKM P14618 1/20 0.46
KDM4E B2RXH2 2/20 0.46
POLB P06746 1/20 0.46
ESR2 Q92731 1/20 0.46
HSD17B10 Q99714 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
GAA P10253 1/20 0.45
RAB9A P51151 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
NR3C1 P04150 1/20 0.45
CYP3A4 P08684 2/20 0.44
VEGFA P15692 1/20 0.44
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
CYP1A2 P05177 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7294928 0.87 PDE4B (0.68) PDE4APDE4BPDE4CPDE4DKDM4E
SCHEMBL2645169 0.79 GSTP1 (0.44) KDM4EPOLBHSD17B10CYP3A4ALDH1A1
SCHEMBL13495999 0.76 PDE4A (0.55) PDE4APDE4BPDE4CPDE4DGFER
SCHEMBL14492203 0.74 PDE4A (0.72) PDE4APDE4BPDE4CPDE4DGFER
SCHEMBL7293719 0.72 PDE4A (1.00) PDE4APDE4BPDE4CPDE4DKDM4E
SCHEMBL426375 0.71 PDE4A (0.64) PDE4APDE4BPDE4CPDE4DGFER
SCHEMBL11300173 0.71 PDE4A (0.48) PDE4APDE4BPDE4CPDE4DGFER
SCHEMBL16501028 0.71 PKM (0.48) PDE4APDE4BPDE4CPDE4DGFER
SCHEMBL5969365 0.70 TSHR (0.52) KDM4EL3MBTL1GAAALDH1A1LMNA
SCHEMBL7091735 0.69 SLC6A3 (0.40) KDM4EPOLBHSD17B10GAARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1214345-B1 AGENTS FOR TREATING HUMAN DISEASES, ESPECIALLY FOR TREATING TUMORS SUCH AS COLONIC CANCERS AND MELANOMAS OR FOR REGENERATING TISSUE AND PROMOTING HAIR GROWTH MAX DELBRUECK CENTRUM (DE) 2004-12-29 EP claimed
US-7067474-B1 Agents for treating human illnesses based on β-catenin, and the production and use thereof MAX-DELBRUCK-CENTRUM FUR MOLEKULARE MEDIZIN (DE) 2006-06-27 US disclosed
EP-0663395-B1 3-(phenylalkylaminoalkyloxy)-5-phenylpyrazole derivatives, process and intermediates for their preparation and their use as cardiac rhythm reduction agent SOLVAY PHARM GMBH (DE) 2001-05-16 EP disclosed
US-5679699-A ANTIISCHEMIC AGENTS, HEART RATE LOWERING AGENTS KALI-CHEMIE PHARMA GMBH (DE) 1997-10-21 US disclosed
US-5547967-A HYPOTENSIVE AGENT, ANTIISCHEMIC AGENT KALI-CHEMIE PHARMA GMBH (DE) 1996-08-20 US disclosed
EP-0663395-A1 3-(phenylalkylaminoalkyloxy)-5-phenylpyrazole derivatives, process and intermediates for their preparation and their use as cardiac rhythm reduction agent Kali-Chemie Pharma GmbH (DE) 1995-07-19 EP disclosed